Literature DB >> 11160184

Expression of the C-C chemokine receptor CCR3 in human airway epithelial cells.

C Stellato1, M E Brummet, J R Plitt, S Shahabuddin, F M Baroody, M C Liu, P D Ponath, L A Beck.   

Abstract

Chemokine-induced eosinophil chemotaxis is mediated primarily through the C-C chemokine receptor, CCR3. We have now detected CCR3 immunoreactivity on epithelial cells in biopsies of patients with asthma and other respiratory diseases. CCR3 mRNA was detected by Northern blot analysis after TNF-alpha stimulation of the human primary bronchial epithelial cells as well as the epithelial cell line, BEAS-2B; IFN-gamma potentiated the TNF-alpha-induced expression. Western blots and flow cytometry confirmed the expression of CCR3 protein. This receptor is functional based on studies demonstrating eotaxin-induced intracellular Ca(2+) flux and tyrosine phosphorylation of cellular proteins. The specificity of this functional response was confirmed by blocking these signaling events with anti-CCR3 mAb (7B11) or pertussis toxin. Furthermore, (125)I-eotaxin binding assay confirmed that CCR3 expressed on epithelial cells have the expected ligand specificity. These studies indicate that airway epithelial cells express CCR3 and suggest that CCR3 ligands may influence epithelial cell functions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160184     DOI: 10.4049/jimmunol.166.3.1457

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

Review 1.  Chemokines--linking receptors to response.

Authors:  Malcolm L Watson
Journal:  Immunology       Date:  2002-02       Impact factor: 7.397

2.  Temporal production of CCL28 corresponds to eosinophil accumulation and airway hyperreactivity in allergic airway inflammation.

Authors:  Alison E John; Molly S Thomas; Aaron A Berlin; Nicholas W Lukacs
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

3.  A central regulatory role for eosinophils and the eotaxin/CCR3 axis in chronic experimental allergic airway inflammation.

Authors:  Patricia C Fulkerson; Christine A Fischetti; Melissa L McBride; Lynn M Hassman; Simon P Hogan; Marc E Rothenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-23       Impact factor: 11.205

Review 4.  Pharmacological management of nasal polyposis.

Authors:  Claus Bachert; Jean-Baptiste Watelet; Philippe Gevaert; Paul Van Cauwenberge
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  The airway smooth muscle CCR3/CCL11 axis is inhibited by mast cells.

Authors:  R Saunders; A Sutcliffe; L Woodman; D Kaur; S Siddiqui; Y Okayama; A Wardlaw; P Bradding; C Brightling
Journal:  Allergy       Date:  2008-09       Impact factor: 13.146

6.  CCL26-targeted siRNA treatment of alveolar type II cells decreases expression of CCR3-binding chemokines and reduces eosinophil migration: implications in asthma therapy.

Authors:  Younes J Errahali; Equar Taka; Barack O Abonyo; Ann S Heiman
Journal:  J Interferon Cytokine Res       Date:  2009-04       Impact factor: 2.607

7.  Post-transcriptional silencing of CCR3 downregulates IL-4 stimulated release of eotaxin-3 (CCL26) and other CCR3 ligands in alveolar type II cells.

Authors:  Equar Taka; Younes J Errahali; Barack O Abonyo; David M Bauer; Ann S Heiman
Journal:  Cytokine       Date:  2008-11-26       Impact factor: 3.861

8.  Novel peptide nanoparticle-biased antagonist of CCR3 blocks eosinophil recruitment and airway hyperresponsiveness.

Authors:  Milica Grozdanovic; Kimberly G Laffey; Hazem Abdelkarim; Ben Hitchinson; Anantha Harijith; Hyung-Geon Moon; Gye Young Park; Lee K Rousslang; Joanne C Masterson; Glenn T Furuta; Nadya I Tarasova; Vadim Gaponenko; Steven J Ackerman
Journal:  J Allergy Clin Immunol       Date:  2018-05-17       Impact factor: 10.793

Review 9.  Effects of allergenic extracts on airway epithelium.

Authors:  Laurel J Gershwin
Journal:  Curr Allergy Asthma Rep       Date:  2007-09       Impact factor: 4.806

10.  P2X4R promotes airway remodeling by acting on the phenotype switching of bronchial smooth muscle cells in rats.

Authors:  Li Wang; Xiaoqian Feng; Bing Hu; Qingqing Xia; Xiuqin Ni; Yinli Song
Journal:  Purinergic Signal       Date:  2018-11-01       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.